What were the vibes like at BIO 2026? STAT reporters take you inside the annual industry conference on the latest episode of ...

Biotech investors, executives and analysts worry that blanket bans on deals with Chinese companies could curb domestic ...

INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a late-stage biotechnology company focused on inflammation and immunology, today announced that the UK Medicines & Healthcare products Regulatory Agency ...

Biotech executives reveal concerns over Chinese biotech, the profitability of AI, and the durability of Trump's drug price ...

Helen Croydon is an author and former journalist who now specializes in personal branding. She is founder of Thought Leadership PR agency. When putting yourself forward for media opportunities, ...

If you’re a candidate for C-suite, Partner, or Board roles, you’ll be asked for a bio as part of the process. For some roles reporting to the C-suite, you may need a bio as well. Employers evaluating ...

AI drug discovery cleared its first Phase IIa clinical test in 2025, as BIO 2026 confirmed the shift from speculation to ...